Delivery Order SPE2DB20D2001-SPE2DB23FM50D
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,401.80 firm fixed-price delivery order is for the supply of Lantus Solostar, a 100 unit/mL insulin product, with a performance period through January 19, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of 4,565,520,096 units of the Lantus Solostar 100 unit/mL 3mL insulin medication. The $3,580.62 firm fixed-price delivery order has an ultimate completion date of August 21, 2024. This contract is not set aside for any specific business type. Amerisourcebergen has been awarded numerous indefinite delivery contracts (IDCs) by...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,992.84 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of Lantus Solostar 100 unit/ml 3ml, a prescription insulin medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued up to $999,999,999.00 through December 2025. Under this IDC, Amerisourcebergen provides a comprehensive...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The $2,527.66 firm fixed-price delivery order is for the supply of Lantus Solostar 100 Unit/mL 3mL, a prescription insulin product. The contract has an ultimate completion date of April 18, 2024. Amerisourcebergen, through its Corporate Office division, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,828.91 firm fixed-price contract is for the supply of Lantus Solostar 100 unit/mL 3mL, a specialty medication used for diabetes management. The contract has a completion date of May 9, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,729.38 firm fixed price delivery order is for the supply of 4,565,752,686 units of Lantus Solostar, a brand-name insulin product. The contract has a completion date of September 11, 2024 and was awarded on September 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
- This federal contract award, valued at $2,383.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lantus Solostar 100 unit/mL 3mL, a specialty insulin medication, to support military healthcare programs. This is a Firm Fixed Price Delivery Order with an ultimate completion date of August 3, 2023. The contract is not designated with a set-aside requirement,...
- This is a $5,105.58 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lantus Solostar 100 unit/mL 3mL, a specialized insulin medication. The contract has a completion date of June 16, 2023 and utilizes a firm-fixed price pricing structure. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,388.08 firm fixed-price delivery order is for the supply of Lantus Solostar 100 unit/mL 3mL insulin medication. The award is not designated with a set-aside requirement, indicating open competition. The contract is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at up to $1,187.60, is for the delivery of Lantus Solostar 100 unit/mL 3mL, a type of insulin medication. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB23FM50DDelivery Order
This contract award, valued at $12,007.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lantus Solostar, a 100 unit/mL, 3mL insulin product, with an ultimate completion date of April 20, 2023. This is a firm-fixed-price delivery order contract, and there is no set-aside designation, indicating open competition. In addition to this specific delivery order, AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 4/19/23 |